ReviewMedicine international
Unveiling the potential use of bioprinting materials in directing stem cell fate for cartilage regeneration: Focusing on induced pluripotent stem cells and enhanced lubrication (Review).
Review in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cartilage is a strong, yet flexible, type of connective tissue found in various parts of the body. Cartilage that covers the ends of bones in joints, referred to as articular cartilage, is frequently damaged during injuries and osteoarthritis (OA). Lack of blood vessels and nerves in the cartilage limits its self-renewal capacity, rendering cartilage regeneration a critical challenge. Three-dimensional (3D) bioprinting provides a promising approach for cartilage regeneration by depositing bioink layer by layer to create a 3D structure of more complex tissues such as cartilage, with clinically relevant sizes and mimicking the native shape and natural microenvironment. The present review discusses the potential of bioprinting materials to direct the fate of induced pluripotent stem cells (iPSCs) towards chondrocytes, while simultaneously enhancing lubrication. This will be achieved by incorporating iPSCs, natural polymers, synthetic polymers and lubricants such as lubricin, growth factors and signaling molecules that are involved in chondrogenesis. By optimizing bioink formulation and other parameters in bioprinters, the production of tissues in a precisely controlled manner is ensured, and limitations in current treatments for degenerative diseases such as OA can be avoided. Researchers have developed various complex and functional tissues and organs using bioprinting with successful animal trials, and are in the process of developing patient-specific iPSCs to generate personalized cartilage grafts having high and prolonged regenerative ability with further enhanced lubrication. The present review aimed to provide hope for patients suffering from cartilage degeneration by demonstrating the potential of 3D bioprinting for effective cartilage regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.